These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6948897)

  • 1. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
    Ball ED; Kadushin JM; Schacter B; Fanger MW
    J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies reactive with acute myelogenous leukemia cells.
    Linker-Israeli M; Billing RJ; Foon KA; Terasaki PI
    J Immunol; 1981 Dec; 127(6):2473-7. PubMed ID: 7028873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies reactive with human myeloid leukaemia cells.
    Ball ED; Fanger MW
    Clin Exp Immunol; 1982 Jun; 48(3):655-65. PubMed ID: 6956470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.
    Tatake RJ; Maniar HS; Chiplunkar SV; Somasundaram R; Amin MK; Saikia T; Gangal SG
    J Clin Lab Immunol; 1990 Feb; 31(2):87-91. PubMed ID: 1966990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
    Howell AL; Miller R; Keefe KA; McIntyre OR; Stockner M; Sullivan R; Hibbert SR; Noelle RJ; Ball ED
    Exp Hematol; 1988 Mar; 16(3):176-83. PubMed ID: 3422192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity of monoclonal anti-K 562 antibodies with cells of leukemia- and lymphoma-patients.
    Hering S; Böttger V; Baryschnikow AJ; Micheel B
    Arch Geschwulstforsch; 1985; 55(1):9-16. PubMed ID: 3885896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu
    Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibodies reactive with human myelomonocytic leukemia cells.
    Posner MR; Santos DJ; Elboim HS; Tumber MB; Frackelton AR
    Cancer Res; 1989 Apr; 49(7):1665-70. PubMed ID: 2924315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies against the human leukemia cell line K 562.
    Böttger V; Hering S; Jantscheff P; Micheel B
    Arch Geschwulstforsch; 1985; 55(1):1-8. PubMed ID: 3885895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23.
    Maliszewski CR; Ball ED; Graziano RF; Fanger MW
    J Immunol; 1985 Sep; 135(3):1929-36. PubMed ID: 3894519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
    Haynes BF; Hemler M; Cotner T; Mann DL; Eisenbarth GS; Strominger JL; Fauci AS
    J Immunol; 1981 Jul; 127(1):347-51. PubMed ID: 6787129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells.
    Martens AC; Johnson RJ; Kaizer H; Hagenbeek A
    Exp Hematol; 1984 Sep; 12(8):667-71. PubMed ID: 6386506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Pan-myeloid" reagent: the monoclonal antibody MCS-2 in the routine immunodiagnostic service of leukemia phenotyping.
    Drexler HG; Sagawa K; Menon M; Minowada J
    Jpn J Cancer Res; 1985 Mar; 76(3):235-9. PubMed ID: 3922842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody to myelogenous leukemia: isolation and characterization.
    Malcolm AJ; Shipman RC; Logan PM; Levy JG
    Exp Hematol; 1984 Aug; 12(7):539-47. PubMed ID: 6589167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies to the antigen of myeloid cells].
    Kryzhanov MA; Baryshnikov AIu; Tupitsin NN; Sokolov AV; Frenkel' MA
    Biull Eksp Biol Med; 1987 Jul; 104(7):75-7. PubMed ID: 3620654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.